Article ID Journal Published Year Pages File Type
10956212 Molecular and Cellular Endocrinology 2013 11 Pages PDF
Abstract
► Vasoactive intestinal peptide (VIP) increases adhesion of renal carcinoma cells. ► VIP decreases migration and extracellular-matrix degradation in tumor renal cells. ► VIP lowers tumor VEGF expression and nuclear levels of β-catenin and NFκB p50 unit. ► VIP acts through VPAC1/2 receptors (they were blocked with JV-1-53 antagonist). ► VIP and its agonists have a potential therapeutical role in clear renal cell cancer.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cell Biology
Preview
Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma
Authors
, , , , , ,